Michael Beaubaire
Director/Miembro de la Junta en Erad Therapeutics, Inc. .
Perfil
Michael Beaubaire is currently a director at Erad Therapeutics, Inc. He was previously the Chairman-Scientific Advisory Board at Lincoln Park Capital LLC from 2011 to 2018.
He also served as a director at Applied BioSciences Corp.
Dr. Beaubaire holds a doctorate degree from Northwestern University and undergraduate degrees from The Wharton School of the University of Pennsylvania and The College of Arts & Sciences.
Cargos activos de Michael Beaubaire
| Empresas | Cargo | Inicio |
|---|---|---|
| Erad Therapeutics, Inc. | Director/Miembro de la Junta | 01/05/2016 |
Antiguos cargos conocidos de Michael Beaubaire.
| Empresas | Cargo | Fin |
|---|---|---|
Lincoln Park Capital LLC
 Lincoln Park Capital LLC Investment ManagersFinance Lincoln Park Capital LLC (Lincoln Park Capital) is a private equity/venture capital firm founded in 2010 by Joshua B. Scheinfeld, Jonatham I.Cope, Richard C. Vogel and Robert A. Garcia. The firm is headquartered in Chicago, Illinois. | Inversor de Capital Privado | 28/02/2018 |
| APPLIED BIOSCIENCES CORP. | Director/Miembro de la Junta | - |
Formación de Michael Beaubaire.
| Northwestern University | Doctorate Degree |
| The College of Arts & Sciences | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| APPLIED BIOSCIENCES CORP. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Lincoln Park Capital LLC
Lincoln Park Capital LLC Investment ManagersFinance Lincoln Park Capital LLC (Lincoln Park Capital) is a private equity/venture capital firm founded in 2010 by Joshua B. Scheinfeld, Jonatham I.Cope, Richard C. Vogel and Robert A. Garcia. The firm is headquartered in Chicago, Illinois. | Finance |
| Erad Therapeutics, Inc. |
- Bolsa de valores
- Insiders
- Michael Beaubaire
